Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bhagwan Yadav

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Cancers|July 2, 2021
High miR-30 Expression Associates with Improved Breast Cancer Patient Survival and Treatment OutcomeMaral Jamshidi, Rainer Fagerholm, Taru A Muranen, et al.
Nature Cell Biology|February 1, 2024
Mechanical forces across compartments coordinate cell shape and fate transitions to generate tissue architectureClémentine Villeneuve, Ali Hashmi, Irene Ylivinkka, et al.
European Urology|May 11, 2016
Comprehensive Drug Testing of Patient-derived Conditionally Reprogrammed Cells from Castration-resistant Prostate CancerKhalid Saeed, Vesa Rahkama, Samuli Eldfors, et al.
Science Translational Medicine|July 20, 2018
PP2A inhibition is a druggable MEK inhibitor resistance mechanism in KRAS-mutant lung cancer cellsOtto Kauko, Caitlin M O'Connor, Evgeny Kulesskiy, et al.
Oncoimmunology|August 21, 2019
Immunological monitoring of newly diagnosed CML patients treated with bosutinib or imatinib first-lineAnna Kreutzman, Bhagwan Yadav, Tim H Brummendorf, et al.
The Journal of Biological Chemistry|February 20, 2020
Phosphoproteome and drug-response effects mediated by the three protein phosphatase 2A inhibitor proteins CIP2A, SET, and PME-1Otto Kauko, Susumu Y Imanishi, Evgeny Kulesskiy, et al.
Frontiers in Immunology|December 17, 2020
Adult-Onset Anti-Citrullinated Peptide Antibody-Negative Destructive Rheumatoid Arthritis Is Characterized by a Disease-Specific CD8+ T Lymphocyte SignatureTiina Kelkka, Paula Savola, Dipabarna Bhattacharya, et al.
Blood|June 17, 2017
JAK1/2 and BCL2 inhibitors synergize to counteract bone marrow stromal cell-induced protection of AMLRiikka Karjalainen, Tea Pemovska, Mihaela Popa, et al.
Frontiers in Immunology|June 17, 2021
Corrigendum: Adult-Onset Anti-Citrullinated Peptide Antibody-Negative Destructive Rheumatoid Arthritis Is Characterized by a Disease-Specific CD8+ T Lymphocyte SignatureTiina Kelkka, Paula Savola, Dipabarna Bhattacharya, et al.
The FEBS Journal|July 17, 2025
In vivo modeling of lethal congenital contracture syndrome 1 suggests pathomechanisms in cellular stress responsesTomáš Zárybnický, Sonja Lindfors, Saana Metso, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Cancers|July 2, 2021
High miR-30 Expression Associates with Improved Breast Cancer Patient Survival and Treatment OutcomeMaral Jamshidi, Rainer Fagerholm, Taru A Muranen, et al.
Nature Cell Biology|February 1, 2024
Mechanical forces across compartments coordinate cell shape and fate transitions to generate tissue architectureClémentine Villeneuve, Ali Hashmi, Irene Ylivinkka, et al.
European Urology|May 11, 2016
Comprehensive Drug Testing of Patient-derived Conditionally Reprogrammed Cells from Castration-resistant Prostate CancerKhalid Saeed, Vesa Rahkama, Samuli Eldfors, et al.
Science Translational Medicine|July 20, 2018
PP2A inhibition is a druggable MEK inhibitor resistance mechanism in KRAS-mutant lung cancer cellsOtto Kauko, Caitlin M O'Connor, Evgeny Kulesskiy, et al.
Oncoimmunology|August 21, 2019
Immunological monitoring of newly diagnosed CML patients treated with bosutinib or imatinib first-lineAnna Kreutzman, Bhagwan Yadav, Tim H Brummendorf, et al.
The Journal of Biological Chemistry|February 20, 2020
Phosphoproteome and drug-response effects mediated by the three protein phosphatase 2A inhibitor proteins CIP2A, SET, and PME-1Otto Kauko, Susumu Y Imanishi, Evgeny Kulesskiy, et al.
Frontiers in Immunology|December 17, 2020
Adult-Onset Anti-Citrullinated Peptide Antibody-Negative Destructive Rheumatoid Arthritis Is Characterized by a Disease-Specific CD8+ T Lymphocyte SignatureTiina Kelkka, Paula Savola, Dipabarna Bhattacharya, et al.
Blood|June 17, 2017
JAK1/2 and BCL2 inhibitors synergize to counteract bone marrow stromal cell-induced protection of AMLRiikka Karjalainen, Tea Pemovska, Mihaela Popa, et al.
Frontiers in Immunology|June 17, 2021
Corrigendum: Adult-Onset Anti-Citrullinated Peptide Antibody-Negative Destructive Rheumatoid Arthritis Is Characterized by a Disease-Specific CD8+ T Lymphocyte SignatureTiina Kelkka, Paula Savola, Dipabarna Bhattacharya, et al.
The FEBS Journal|July 17, 2025
In vivo modeling of lethal congenital contracture syndrome 1 suggests pathomechanisms in cellular stress responsesTomáš Zárybnický, Sonja Lindfors, Saana Metso, et al.
Pageof 4